Attached files

file filename
S-1/A - Arno Therapeutics, Incv209332_s1a.htm
EX-23.1 - Arno Therapeutics, Incv209332_ex23-1.htm
Exhibit 23.2

Consent of Independent Registered Public Accounting Firm   
 
We consent to the use in this Pre-effective Amendment No. 2 to the Registration Statement of Arno Therapeutics, Inc. on Form S-1 of our report dated March 31, 2009, on the financial statements of Arno Therapeutics, Inc. and to the reference to us under the heading “Experts” in the prospectus.

/s/     Hays & Company LLP
 
New York, New York
January 28, 2011